Good morning :)
Place Order
Add to Watchlist

Dishman Carbogen Amcis Ltd

DCAL

Dishman Carbogen Amcis Ltd

DCAL
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹3,474 cr, stock is ranked 771
High RiskStock is 5.32x as volatile as Nifty
216.652.23% (-4.95)
216.652.23% (-4.95)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹3,474 cr, stock is ranked 771
High RiskStock is 5.32x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹3,474 cr, stock is ranked 771
High RiskStock is 5.32x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-22.520.60
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.725.800.58%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dishman Carbogen Amicis Limited is an India-based contract research and manufacturing services (CRAMS) company. The Company is engaged in the process of research and development to late-stage clinical and commercial manufacturing

Investor Presentation

View older 

May 23, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7%, vs industry avg of 8.01%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 16.39% to 13.87%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue0.457.131,739.821,740.482,112.422,088.061,950.482,184.112,440.692,607.42
Raw Materialssubtract0.000.00329.58402.19378.01476.38434.77460.50624.992,353.03
Power & Fuel Costsubtract0.0049.4748.3356.1460.2641.8762.7387.83
Employee Costsubtract0.00596.02625.40714.64762.27872.91981.491,035.27
Selling & Administrative Expensessubtract5.08147.69136.29190.73124.58113.81147.71197.65
Operating & Other expensessubtract0.05138.4737.23167.18122.55196.60171.53183.13
Depreciation/Amortizationsubtract0.000.00213.50211.42240.38282.87307.94307.59280.72301.60
Interest & Other Itemssubtract0.940.9949.0148.8356.5561.9547.6156.8185.69113.45
Taxes & Other Itemssubtract0.000.1270.6576.2298.4638.69100.10-22.26-24.79-6.41
EPS-19.6035.6011,634.4019.1513.039.96-10.531.15-1.90-9.84
DPS0.000.001.200.000.200.000.000.000.000.00
Payout ratio0.000.000.000.000.020.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

May 12PDF
Feb 11PDF
FY 2022

Annual report

PDF

Investor Presentation

May 11PDF
Feb 4PDF
Oct 28PDF
Aug 12PDF
FY 2023

Annual report

PDF

Investor Presentation

May 23PDF
Feb 10PDF
Nov 11PDF
Aug 9PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareLabs & Life Sciences Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Dishman Carbogen Amcis Ltd-116.590.60
Divi's Laboratories Ltd51.057.290.86%
Syngene International Ltd58.857.550.18%
Aarti Pharmalabs Ltd20.772.580.45%

Price Comparison

Compare DCAL with any stock or ETF
Compare DCAL with any stock or ETF
DCAL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.32%3.45%0.24%8.61%28.39%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '236.20%7.20%9.34%8.90%8.80%8.61%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Dishman Carbogen Amcis Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
HSBC Flexi Cap Fund - Growth - Direct Plan

Growth
1.7436%1.44%0.40%50/78 (+8)
quant Healthcare Fund - Growth - Direct Plan

Growth
0.4108%5.40%5.40%9/28 (+4)
Quant Value Fund - Direct Plan Growth Growth

Growth
0.2608%0.81%0.81%44/47 (-1)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 12, 2019

Final
Final | Div/Share: ₹0.20

Dividend/Share

0.20

Ex DateEx Date

Sep 12, 2019